Bispecific Antibodies News

Aclaris Therapeutics ATI-052 Shows Promising 45-Day Half-Life in Phase 1a Trial Results

2 min

Tovecimig Shows 56% Reduction in Cancer Progression Risk in Biliary Tract Cancer Trial

2 min

Akeso's Cadonilimab Shows Promising Survival Benefit in Advanced Pancreatic Cancer Phase II Trial

Oncology - Pancreatic Cancer · 3 min

EpiBiologics Begins Phase 1 Trial of EPI-326 Bispecific Antibody for EGFR-Driven Cancers

2 min